BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16719821)

  • 1. ACE inhibitor-angiotensin receptor blocker combinations: a clinician's perspective.
    Doulton TW
    Mini Rev Med Chem; 2006 May; 6(5):491-7. PubMed ID: 16719821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.
    Düsing R; Sellers F
    Curr Med Res Opin; 2009 Sep; 25(9):2287-301. PubMed ID: 19635044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S; Roughead EE; Bartlett LE
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O; Laroche P; Vidal JS; Pannier B; Postel-Vinay N; Vaisse B; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY; Muo CH; Sung FC; Ho HC; Lee YT
    Int J Cardiol; 2016 Jul; 215():114-9. PubMed ID: 27111172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
    J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway.
    Heerspink HJ
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):290-9. PubMed ID: 21782135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational Study of Brain Atrophy and Cognitive Decline Comparing a Sample of Community-Dwelling People Taking Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Over Time.
    Moran C; Xie K; Poh S; Chew S; Beare R; Wang W; Callisaya M; Srikanth V
    J Alzheimers Dis; 2019; 68(4):1479-1488. PubMed ID: 30909218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses.
    Segura J; Praga M; Campo C; Rodicio JL; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):43-7. PubMed ID: 12692753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?
    Segura J; Christiansen H; Campo C; Ruilope LM
    Curr Hypertens Rep; 2003 Oct; 5(5):426-9. PubMed ID: 12948436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prescribing and delirium in the ICU-A secondary analysis.
    Mulkey MA; Khan S; Perkins A; Gao S; Wang S; Campbell N; Khan B
    J Am Geriatr Soc; 2023 Jun; 71(6):1873-1880. PubMed ID: 36905601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there meaningful differences in blood pressure control with current antihypertensive agents?
    Oparil S
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):14S-21S. PubMed ID: 11824870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker.
    Tanemoto M; Abe T; Obara N; Abe M; Satoh F; Ito S
    Hypertens Res; 2003 Oct; 26(10):863-8. PubMed ID: 14621191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
    Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JF; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Manfreda VM; Gentile G; Strippoli GF
    Nephrol Dial Transplant; 2011 Sep; 26(9):2827-47. PubMed ID: 21372254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.